Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Of Efficacy Of COVID-19 Convalescent Plasma Versus Standard Plasma In The Early Care Of COVID-19 Patients Hospitalized Outside Intensive Care Units.

NCT04372979 is registered in ClinicalTrials.gov with Direction Centrale du Service de Santé des Armées as lead sponsor.

NCT NCT04372979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04372979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Of Efficacy Of COVID-19 Convalescent Plasma Versus Standard Plasma In The Early Care Of COVID-19 Patients Hospitalized Outside Intensive Care Units.
Lead sponsor
Direction Centrale du Service de Santé des Armées
Phase
Phase 3
Overall status
Terminated
Start date
September 14, 2020
Completion date
June 1, 2021
Enrollment
18 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19